News
Read all about it
For general press and media enquiries about Mesothelioma UK, please contact Simon Gribbon on 07990 583371 or email simon@sandstarcomms.com. If you would like your latest news story or press release to be published in our latest news section below, please send details to meso@sandstarcomms.com for consideration.
Removing asbestos from schools and hospitals would benefit UK economy by almost £12 billion over 50 years, says new report
Latest research also shows that asbestos-related diseases in former school and hospital workers cost the UK economy £1.3 billion per year New...
A Tribute to Mavis Nye
It is hard to find the words to express the depth of sorrow we all feel at Mesothelioma UK at the passing of Mavis Nye. Mavis feels like one of us...
Mesothelioma UK bids a fond farewell to Clinical Nurse Specialist Sarah Morgan
Mesothelioma UK is bidding a fond farewell to Sarah Morgan, Mesothelioma UK Clinical Nurse Specialist and lead for Project Cymru. Sarah is now...
Leicestershire and Rutland Freemasons donates £20,000 to support the work of Mesothelioma UK
Leicestershire and Rutland Freemasons has donated £20,000 to Mesothelioma UK. The funding will help to support the vital work that the charity does...
Nivolumab treatment cleared for off-label use with mesothelioma patients in Scotland
Decision made by National Cancer Medicines Advisory Group for asbestos-related cancer patients The National Cancer Medicines Advisory Group (NCMAG)...
Memorial sculpture honouring mesothelioma patients in the Armed Forces to be unveiled at National Memorial Arboretum
A major stone sculpture honouring all serving and veteran members of the British Armed Forces with the asbestos-related cancer, mesothelioma, is set...
New MINNOW study aims to understand the mental health impacts of living with mesothelioma on patients and their informal carers
This week sees the launch of the latest research report from the Mesothelioma UK Research Centre at the University of Sheffield. Funded by...
Should I consider the option of surgery to remove mesothelioma? The results of MARS 2
By Professor Eric Lim, Consultant Thoracic Surgeon at the Royal Brompton Hospital and Chief Investigator of the MARS 2 clinical trial MARS 2, a UK...
New data offers update on MAGS study findings
Back in 2020, the Mesothelioma Patient Experience Research Group at the University of Sheffield launched the Healthcare Worker Mesothelioma Asbestos...
First Clinical Nurse Specialist appointed at University College Hospital for care and treatment of mesothelioma patients
Catherine Stoten has been appointed as a new Mesothelioma UK Clinical Nurse Specialist to provide care and support for mesothelioma...
Removing asbestos from schools and hospitals would benefit UK economy by almost £12 billion over 50 years, says new report
Latest research also shows that asbestos-related diseases in former school and hospital workers cost the UK economy £1.3 billion per year New research commissioned by asbestos-related cancer charity, Mesothelioma UK, reveals the true cost to the UK economy of asbestos...
A Tribute to Mavis Nye
It is hard to find the words to express the depth of sorrow we all feel at Mesothelioma UK at the passing of Mavis Nye. Mavis feels like one of us and what she has achieved, the people she has helped, the awareness she has created is immeasurable. She will always be...
Mesothelioma UK bids a fond farewell to Clinical Nurse Specialist Sarah Morgan
Mesothelioma UK is bidding a fond farewell to Sarah Morgan, Mesothelioma UK Clinical Nurse Specialist and lead for Project Cymru. Sarah is now retiring, having joined us in 2017 after a long and distinguished nursing career in palliative care and lung cancer. She...
Leicestershire and Rutland Freemasons donates £20,000 to support the work of Mesothelioma UK
Leicestershire and Rutland Freemasons has donated £20,000 to Mesothelioma UK. The funding will help to support the vital work that the charity does in supporting the families of, and patients diagnosed with mesothelioma, a cancer caused by asbestos. Freemasonry in...
Nivolumab treatment cleared for off-label use with mesothelioma patients in Scotland
Decision made by National Cancer Medicines Advisory Group for asbestos-related cancer patients The National Cancer Medicines Advisory Group (NCMAG) has supported the off-label use of nivolumab in Scotland for the treatment of mesothelioma, the asbestos-related cancer....